BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Valent P, Akin C, Nedoszytko B, Bonadonna P, Hartmann K, Niedoszytko M, Brockow K, Siebenhaar F, Triggiani M, Arock M, Romantowski J, Górska A, Schwartz LB, Metcalfe DD. Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine. Int J Mol Sci 2020;21:E9030. [PMID: 33261124 DOI: 10.3390/ijms21239030] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]
Number Citing Articles
1 Vorzheva I, Chernyak BA. Drug-induced urticaria and angioedema. Russian Journal of Allergy 2022. [DOI: 10.36691/rja1557] [Reference Citation Analysis]
2 Chantran Y, Hirsch P, Stym-popper G, Barete S, Arock M. Hereditary alpha-tryptasemia: Brief overview of current knowledge and proposal of indications. Revue Française d'Allergologie 2022. [DOI: 10.1016/j.reval.2022.03.015] [Reference Citation Analysis]
3 Valent P, Hartmann K, Bonadonna P, Gülen T, Brockow K, Alvarez-Twose I, Hermine O, Niedoszytko M, Carter MC, Hoermann G, Butterfield JH, Lyons JJ, Sperr WR, Greiner G, Sotlar K, Kluin-Nelemans HC, Schwaab J, Lange M, George TI, Siebenhaar F, Broesby-Olsen S, Jawhar M, Nedoszytko B, Castells M, Orfao A, Gotlib J, Reiter A, Horny HP, Triggiani M, Arock M, Metcalfe DD, Akin C. Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium. J Allergy Clin Immunol Pract 2022;10:1941-50. [PMID: 35623575 DOI: 10.1016/j.jaip.2022.05.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Butterfield JH. Nontryptase Urinary and Hematologic Biomarkers of Mast Cell Expansion and Mast Cell Activation: Status 2022. J Allergy Clin Immunol Pract 2022;10:1974-84. [PMID: 35346887 DOI: 10.1016/j.jaip.2022.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jennings SV, Finnerty CC, Hobart JS, Martín-Martínez M, Sinclair KA, Slee VM, Agopian J, Akin C, Álvarez-Twose I, Bonadonna P, Bowman AS, Brockow K, Bumbea H, de Haro C, Fok JS, Hartmann K, Hegmann N, Hermine O, Kalisiak M, Katelaris CH, Kurz J, Marcis P, Mayne D, Mendoza D, Moussy A, Mudretzkyj G, Vaia NN, Niedoszytko M, Elberink HO, Orfao A, Radia DH, Rosenmeier S, Ribada E, Schinhofen W, Schwaab J, Siebenhaar F, Triggiani M, Tripodo G, Velazquez R, Wielink Y, Wimazal F, Yigit T, Zubrinich C, Valent P. Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond. J Allergy Clin Immunol Pract 2022;10:2039-51. [PMID: 35777651 DOI: 10.1016/j.jaip.2022.06.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pyatilova P, Akin C, Alvarez-Twose I, Arock M, Bonadonna P, Brockow K, Butterfield JH, Broesby-Olsen S, Carter MC, Castells M, George TI, Gotlib J, Greiner G, Gülen T, Hartmann K, Hermine O, Horny HP, Jawhar M, Lange M, Lyons JJ, Maurer M, Metcalfe DD, Nedoszytko B, Niedoszytko M, Orfao A, Reiter A, Schwaab J, Sotlar K, Sperr WR, Triggiani M, Valent P, Siebenhaar F. Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium. J Allergy Clin Immunol Pract 2022;10:2015-24. [PMID: 35724950 DOI: 10.1016/j.jaip.2022.05.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Schmidt TJ, Sellin J, Molderings GJ, Conrad R, Mücke M. Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome. Orphanet J Rare Dis 2022;17:295. [PMID: 35906626 DOI: 10.1186/s13023-022-02439-x] [Reference Citation Analysis]
8 Ritter S, Bowden J, Pattanaik D. A case of perioperative anaphylaxis presenting as hereditary alpha tryptasemia. Ann Allergy Asthma Immunol 2022;129:13-6. [PMID: 35292365 DOI: 10.1016/j.anai.2022.03.011] [Reference Citation Analysis]
9 Coffin PB, Duboc H. Diagnostic and therapeutic approach to persistent abdominal pain beyond irritable bowel syndrome. Aliment Pharmacol Ther 2022. [PMID: 35656644 DOI: 10.1111/apt.17064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Buttgereit T, Gu S, Carneiro-Leão L, Gutsche A, Maurer M, Siebenhaar F. Idiopathic mast cell activation syndrome is more often suspected than diagnosed-A prospective real-life study. Allergy 2022. [PMID: 35364617 DOI: 10.1111/all.15304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Valent P, Hartmann K, Schwaab J, Alvarez-Twose I, Brockow K, Bonadonna P, Hermine O, Niedoszytko M, Carter MC, Hoermann G, Sperr WR, Butterfield JH, Ustun C, Zanotti R, Radia DH, Castells M, Triggiani M, Schwartz LB, Orfao A, George TI, Sotlar K, Gotlib J, Reiter A, Horny HP, Arock M, Akin C, Metcalfe DD. Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice. J Allergy Clin Immunol Pract 2022:S2213-2198(22)00281-1. [PMID: 35342031 DOI: 10.1016/j.jaip.2022.03.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
12 Chatain C, Van der Brempt X. Allergie au venin d’hyménoptère, désordres mastocytaires clonaux et alpha-tryptasémie héréditaire. Revue Française d'Allergologie 2022;62:52-58. [DOI: 10.1016/j.reval.2021.10.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sturm K, Jung H, Maier A. Komorbiditäten (Begleiterkrankungen). Ratgeber Ehlers-Danlos-Syndrome 2022. [DOI: 10.1007/978-3-662-65041-7_3] [Reference Citation Analysis]
14 Valent P, Akin C, Hartmann K, Alvarez-Twose I, Brockow K, Hermine O, Niedoszytko M, Schwaab J, Lyons JJ, Carter MC, Elberink HO, Butterfield JH, George TI, Greiner G, Ustun C, Bonadonna P, Sotlar K, Nilsson G, Jawhar M, Siebenhaar F, Broesby-Olsen S, Yavuz S, Zanotti R, Lange M, Nedoszytko B, Hoermann G, Castells M, Radia DH, Muñoz-Gonzalez JI, Sperr WR, Triggiani M, Kluin-Nelemans HC, Galli SJ, Schwartz LB, Reiter A, Orfao A, Gotlib J, Arock M, Horny HP, Metcalfe DD. Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal. Hemasphere 2021;5:e646. [PMID: 34901755 DOI: 10.1097/HS9.0000000000000646] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 27.0] [Reference Citation Analysis]
15 Romano LA, Oliveira FPS, Pedrosa VF. Mast cells and eosinophilic granule cells in Oncorhynchus mykiss: Are they similar or different? Fish and Shellfish Immunology Reports 2021;2:100029. [DOI: 10.1016/j.fsirep.2021.100029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Jackson CW, Pratt CM, Rupprecht CP, Pattanaik D, Krishnaswamy G. Mastocytosis and Mast Cell Activation Disorders: Clearing the Air. Int J Mol Sci 2021;22:11270. [PMID: 34681933 DOI: 10.3390/ijms222011270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kurin M, Elangovan A, Alikhan MM, Al Dulaijan B, Silver E, Kaelber DC, Cooper G. Irritable bowel syndrome is strongly associated with the primary and idiopathic mast cell disorders. Neurogastroenterol Motil 2021;:e14265. [PMID: 34535952 DOI: 10.1111/nmo.14265] [Reference Citation Analysis]
18 Carter MC, Metcalfe DD. Decoding the intricacies of the mast cell compartment. Br J Haematol 2021. [PMID: 34374078 DOI: 10.1111/bjh.17714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Nguyen SMT, Rupprecht CP, Haque A, Pattanaik D, Yusin J, Krishnaswamy G. Mechanisms Governing Anaphylaxis: Inflammatory Cells, Mediators, Endothelial Gap Junctions and Beyond. Int J Mol Sci 2021;22:7785. [PMID: 34360549 DOI: 10.3390/ijms22157785] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 16.0] [Reference Citation Analysis]
20 Jennings SV, Slee VM, Finnerty CC, Hempstead JB, Bowman AS. Symptoms of mast cell activation: The patient perspective. Ann Allergy Asthma Immunol 2021:S1081-1206(21)00494-4. [PMID: 34271184 DOI: 10.1016/j.anai.2021.07.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Shah H, Eisenbarth S, Tormey CA, Siddon AJ. Behind the scenes with basophils: an emerging therapeutic target. Immunotherapy Advances 2021;1:ltab008. [DOI: 10.1093/immadv/ltab008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
22 Voss M, Kotrba J, Gaffal E, Katsoulis-Dimitriou K, Dudeck A. Mast Cells in the Skin: Defenders of Integrity or Offenders in Inflammation? Int J Mol Sci 2021;22:4589. [PMID: 33925601 DOI: 10.3390/ijms22094589] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
23 Peter J, Krause K, Staubach P, Wu MA, Davis M. Chronic Urticaria and Recurrent Angioedema: Clues to the Mimics. J Allergy Clin Immunol Pract 2021;9:2220-8. [PMID: 33906826 DOI: 10.1016/j.jaip.2021.03.043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Taborska P, Stakheev D, Bartunkova J, Smrz D. Thapsigargin-Stimulated LAD2 Human Mast Cell Line Is a Potent Cellular Adjuvant for the Maturation of Monocyte-Derived Dendritic Cells for Adoptive Cellular Immunotherapy. Int J Mol Sci 2021;22:3978. [PMID: 33921475 DOI: 10.3390/ijms22083978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Sprinzl B, Greiner G, Uyanik G, Arock M, Haferlach T, Sperr WR, Valent P, Hoermann G. Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond. Int J Mol Sci 2021;22:2458. [PMID: 33671092 DOI: 10.3390/ijms22052458] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
26 Boldeanu E, Avram M, Rezmeriţă L. Mast cell activation syndrome — clinical presentation and diagnostic criteria. Alergologia 2021;1:7. [DOI: 10.26416/aler.5.1.2021.4445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Lide B, Mcguire S, Liu H, Chandler C. Mast cell activation syndrome—anesthetic challenges in two different clinical scenarios. J Biomed Res 2019;0:1. [DOI: 10.7555/jbr.36.20220071] [Reference Citation Analysis]